GGrantIndex
Sort

17,828 grants matching crispr

Drosophila resources for modeling human diseases

$359,488
Norbert Perrimon · Harvard Medical School · R24 · FY2017 · OD

RESEARCH PROJECT 2

$359,216
Jeffery S Cox · University Of California, San Francisco · U19 · FY2020 · AI

'Class I and III Multi-subunit CRISPR-Cas Surveillance Complexes: Recognition, Cleavage, Autoimmunity and Inhibition’

$359,200
Dinshaw J Patel · Sloan-Kettering Inst Can Research · R01 · FY2020 · GM

'Class I and III Multi-subunit CRISPR-Cas Surveillance Complexes: Recognition, Cleavage, Autoimmunity and Inhibition’

$359,200
Dinshaw J Patel · Sloan-Kettering Inst Can Research · R01 · FY2021 · GM

'Class I and III Multi-subunit CRISPR-Cas Surveillance Complexes: Recognition, Cleavage, Autoimmunity and Inhibition’

$359,200
Dinshaw J Patel · Sloan-Kettering Inst Can Research · R01 · FY2022 · GM

'Class I and III Multi-subunit CRISPR-Cas Surveillance Complexes: Recognition, Cleavage, Autoimmunity and Inhibition’

$359,200
Dinshaw J Patel · Sloan-Kettering Inst Can Research · R01 · FY2019 · GM

IDENTIFYING THE MOLECULAR MECHANISMS OF PROSTATE TUMORIGENESIS ASSOCIATED WITH MULTIGENIC 3P13-14 LOCUS LOSS USING A NOVEL CRISPR-ORGANOID PLATFORM

$359,200
Sloan-Kettering Institute For Cancer Research · · FY2019 · Department of the Army

Molecular basis of tumor suppression by Cdk4/6 inhibition

$359,169
Seth Michael Rubin · University Of California Santa Cruz · R01 · FY2021 · CA

The role of pyruvate kinase as a therapeutic target in T-ALL

$359,138
Daniel Herranz · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA

The role of pyruvate kinase as a therapeutic target in T-ALL

$359,138
Daniel Herranz · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA

Genome editing, mRNA suppression and chain termintion as therapy for Lafora Epilepsy

$359,094
Berge A Minassian · University Of Kentucky · P01 · FY2018 · NS

UNCOVER NOVEL REGULATORS OF BETA CELL DIFFERENTIATION THROUGH UNBIASED, GENOME-SCALE CRISPR SCREENING

$359,078
Sloan-Kettering Institute For Cancer Research · · FY2020 · Department of the Army

Bay Area CRISPR Reporters

$359,070
Michael T McManus · University Of California, San Francisco · U42 · FY2018 · OD

Off-The-Shelf Dual Targeted NK Cells For NHL

$359,065
Daniel J Weisdorf · University Of Minnesota · P01 · FY2024 · CA

Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation

$359,009
Michael Richard Green · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Manifold representations and active learning for 21 st century biology

$358,858
Bonnie Berger · Massachusetts Institute Of Technology · R35 · FY2023 · GM

RUI: Evolutionary origins of the vertebrate paired appendage gene regulatory network

$358,803
Marcus C Davis · Kennesaw State University Research And Service Foundation · · FY2017 · BIO

Discovery and functional analysis of novel candidate genes and variants underlying craniofacial diversification in Cyprinodon pupfishes

$358,797
Christopher Herbert Martin · Univ Of North Carolina Chapel Hill · R01 · FY2018 · DE

Epigenetic mechanisms of therapeutic resistance

$358,778
Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2023 · CA

Epigenetic mechanisms of therapeutic resistance

$358,778
Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2022 · CA

Genetic Dissection of Germ Cell Differentiation and Function

$358,752
Michael Buszczak · Ut Southwestern Medical Center · R35 · FY2023 · GM

Epigenetic mechanisms of therapeutic resistance

$358,746
Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2024 · CA

Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma

$358,680
Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Engineering human-derived programmable RNA effectors to retune gene expression

$358,509
Bryan Dickinson · University Of Chicago · R01 · FY2024 · EB

Core A - Chemigenomics

$358,507
Eric Joseph Rubin · Texas A&M Agrilife Research · P01 · FY2019 · AI